Biblio

Found 6 results

Filters: Keyword is Cost-Benefit Analysis [Clear All Filters]

2024

Michalowsky B, Blotenberg I, Platen M, Teipel S, Kilimann I, Portacolone E, Bohlken J, Rädke A, Buchholz M, Scharf A, et al. Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care: A Secondary Analysis of a Cluster Randomized Clinical Trial. JAMA Netw Open. 2024 ;7(7):e2419282.

2022

Boettiger DC, Lin TKuo. Cost-effectiveness of liposomal amphotericin B for HIV-associated cryptococcal meningitis. Lancet Glob Health. 2022 ;10(12):e1705-e1706.

Maya S, Kahn JG, Lin TK, Jacobs LM, Schmidt LA, Burrough WB, Ghasemzadeh R, Mousli L, Allan M, Donovan M, et al. Indirect COVID-19 health effects and potential mitigating interventions: Cost-effectiveness framework. PLoS One. 2022 ;17(7):e0271523.

2021

Crosson FJ, Covinsky K, Redberg RF. Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?. JAMA Intern Med. 2021 ;181(10):1278-1280.

Lee SJ, Smith AK, L Diaz-Ramirez G, Covinsky KE, Gan S, Chen CL, Boscardin WJ. A Novel Metric for Developing Easy-to-Use and Accurate Clinical Prediction Models: The Time-cost Information Criterion. Med Care. 2021 ;59(5):418-424.

2020

Basu S, Jacobs LM, Epel E, Schillinger D, Schmidt L. Cost-Effectiveness Of A Workplace Ban On Sugar-Sweetened Beverage Sales: A Microsimulation Model. Health Aff (Millwood). 2020 ;39(7):1140-1148.